Melquin-3 Topical Solution
FDA Issues Proposal to Increase Consumer Awareness of Tanning Bed Risks »
"Today, the U.S. Food and Drug Administration issued a proposed order that, if finalized, would reclassify sunlamp products and require labeling to include a recommendation designed to warn young people not to use these devices.
Accordin"...
Read the FDA Issues Proposal to Increase Consumer Awareness of Tanning Bed Risks article »
Melquin-3 Topical Solution
PATIENT INFORMATION
No information provided. Please refer to the WARNINGS and PRECAUTIONS sections.
Last reviewed on RxList: 1/20/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Melquin-3 Topical Solution Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Skin & Beauty
Get beauty tips and body treatments.






